Project Details
Description
A randomized, double-blind, placebo-controlled, phase II study to assess the efficacy and safety of oral vismodegib for the treatment of basal cell carcinoma preceding excision by Mohs micrographic surgery
| Status | Finished |
|---|---|
| Effective start/end date | 10/23/13 → 12/31/15 |
Funding
- GENENTECH, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.